Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fifty 1 Labs's operating cash flow per share for the
six
months ended in Jun. 2024 was $0.00.
Fifty 1 Labs's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Fifty 1 Labs's Operating Cash Flow per Share or its related term are showing as below:
FITY's 3-Year OCF Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.25 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Fifty 1 Labs Operating Cash Flow per Share Related Terms
Fifty 1 Labs Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Fifty 1 Labs's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FITY vs GRPS, KOAN, PTPI: Operating Cash Flow per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Fifty 1 Labs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fifty 1 Labs Price-to-Operating-Cash-Flow vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fifty 1 Labs's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Fifty 1 Labs's Price-to-Operating-Cash-Flow falls into.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $0.00 mean?
Fifty 1 Labs (FITY) has a Operating Cash Flow per Share of $0.00 as of Jun. 2024. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Fifty 1 Labs and its competitors.
Is Fifty 1 Labs' Operating Cash Flow per Share too high?
Fifty 1 Labs' current Operating Cash Flow per Share is $0.00.
How does Fifty 1 Labs' Operating Cash Flow per Share compare to GRPS and KOAN?
Fifty 1 Labs' Operating Cash Flow per Share of $0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Operating Cash Flow per Share is 7.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Drug Manufacturers company?
The median Operating Cash Flow per Share among Drug Manufacturers companies is 7.25, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Fifty 1 Labs and its competitors. For the Drug Manufacturers industry, the median Operating Cash Flow per Share is 7.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fifty 1 Labs's current Operating Cash Flow per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fifty 1 Labs stock overvalued right now?
Fifty 1 Labs (FITY) has a current Operating Cash Flow per Share of $0.00. The current Operating Cash Flow per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Fifty 1 Labs (FITY), the current Operating Cash Flow per Share is $0.00 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FITY has been successfully added to your 
